We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$29B
AUM Growth
+$2.89B
(+11%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
17.32%
Holding
533
New
67
Increased
191
Reduced
199
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$519M |
| 2 |
Pfizer
PFE
|
+$351M |
| 3 |
Eli Lilly
LLY
|
+$212M |
| 4 |
Devon Energy
DVN
|
+$189M |
| 5 |
Cognizant
CTSH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$246M |
| 2 |
US Bancorp
USB
|
+$182M |
| 3 |
Comcast
CMCSA
|
+$118M |
| 4 |
AbbVie
ABBV
|
+$115M |
| 5 |
Coca-Cola Europacific Partners
CCEP
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.57% |
| 2 | Technology | 16.55% |
| 3 | Financials | 16.53% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Staples | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Itaú Unibanco
ITUB
$91.3B
| $116M | 0.4% |
22,269,785
-301,464
| -1% | -$1.69M |
|
77
Alibaba
BABA
$269B
| $115M | 0.4% |
1,105,837
-989,023
| -47% | -$102M |
|
|
AGN
78
DELISTED
Allergan plc
AGN
| $112M | 0.39% |
435,581
+131,157
| +43% | +$32.8M |
|
79
Medtronic
MDT
$107B
| $112M | 0.39% |
1,547,534
-308,381
| -17% | -$21.4M |
|
|
80
AbbVie
ABBV
$458B
| $111M | 0.38% |
1,693,936
-1,817,889
| -52% | -$115M |
|
81
TripAdvisor
TRIP
$1.59B
| $110M | 0.38% |
1,466,920
+830,675
| +131% | +$64.8M |
|
|
AET
82
DELISTED
Aetna Inc
AET
| $101M | 0.35% |
1,140,000
+215,000
| +23% | +$18M |
|
|
MON
83
DELISTED
Monsanto Co
MON
| $100M | 0.35% |
841,156
+396,240
| +89% | +$46M |
|
84
Lowe's Companies
LOW
$116B
| $99.8M | 0.34% |
1,450,000
+85,000
| +6% | +$5.09M |
|
85
Ambev
ABEV
$47.3B
| $98.6M | 0.34% |
15,859,612
+306,388
| +2% | +$1.94M |
|
|
RDC
86
DELISTED
Rowan Companies Plc
RDC
| $98.1M | 0.34% |
4,206,317
+1,122,083
| +36% | +$25.9M |
|
87
T-Mobile US
TMUS
$193B
| $96.8M | 0.33% |
3,592,383
-168,800
| -4% | -$4.67M |
|
88
Lam Research
LRCX
$382B
| $95.8M | 0.33% |
12,069,010
+1,414,770
| +13% | +$11M |
|
89
Omnicom Group
OMC
$22.7B
| $95.4M | 0.33% |
1,230,907
-256,091
| -17% | -$18.7M |
|
90
Royal Caribbean
RCL
$78.7B
| $91.7M | 0.32% |
1,112,117
-396,465
| -26% | -$27.8M |
|
91
Amazon
AMZN
$2.5T
| $89.9M | 0.31% |
5,790,340
-392,900
| -6% | -$6.12M |
|
92
PepsiCo
PEP
$186B
| $89M | 0.31% |
941,651
-9,226
| -1% | -$885K |
|
93
HCA Healthcare
HCA
$84.8B
| $88.2M | 0.3% |
1,201,131
-685,532
| -36% | -$48.2M |
|
|
TFCF
94
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $82.8M | 0.29% |
2,243,156
-806
| -0% | -$27.5K |
|
95
Huntington Bancshares
HBAN
$35.1B
| $81.2M | 0.28% |
7,722,882
-349,738
| -4% | -$3.49M |
|
96
Cooper Companies
COO
$13.7B
| $81.1M | 0.28% |
2,002,052
+1,595,892
| +393% | +$64M |
|
97
Halliburton
HAL
$27.9B
| $79.2M | 0.27% |
2,013,479
+235,044
| +13% | +$11.4M |
|
98
Marathon Petroleum
MPC
$90.3B
| $79.1M | 0.27% |
1,752,122
+270,128
| +18% | +$11.9M |
|
99
Fomento Económico Mexicano
FMX
$43.3B
| $77.8M | 0.27% |
883,235
+16,480
| +2% | +$1.51M |
|
100
Ameren
AEE
$31.5B
| $77.4M | 0.27% |
1,677,617
-3,492
| -0.2% | -$148K |
|
Similar funds
Fidelity International's Q4 2014 Portfolio in Review
As of Q4 2014, Fidelity International held 533 positions worth $29B, up 11% from $26.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fidelity International deployed $1.6B of net new capital in Q4 2014, opening 67 new positions and adding to 191 existing holdings. Its largest new stake was UBS Group: 30,316,557 shares worth $521M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Amgen, an estimated $246M trimmed.
- Fidelity International's largest Q4 2014 buy was UBS Group: 30,316,557 shares worth $521M.
- Fidelity International added most to Pfizer in Q4 2014, an estimated $351M increase.
- Fidelity International's biggest Q4 2014 reduction was Amgen, cutting an estimated $246M.
- Fidelity International fully exited Coca-Cola Europacific Partners in Q4 2014, selling an estimated $102M.
- Fidelity International's ten largest holdings make up 17% of its $29B portfolio in Q4 2014.
- Fidelity International opened 67 new positions and closed 55 in Q4 2014.
- Fidelity International's portfolio value rose 11% quarter-over-quarter to $29B.
Based on Fidelity International's 13F filing for Q4 2014, filed 17 Feb 2015.